VOR

Vor Biopharma (VOR)

Vor Biopharma Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VOR

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/10	05 : 05	GlobeNewswire Inc.	Vor Bio Reports First Quarter 2024 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
2024/05/10	05 : 01	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VOR	Vor Biopharma Inc
2024/05/08	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/05/08	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/05/06	21 : 00	GlobeNewswire Inc.	Vor Bio to Participate in Upcoming Investor Conferences	NASDAQ:VOR	Vor Biopharma Inc
2024/05/04	05 : 01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc
2024/05/03	05 : 01	GlobeNewswire Inc.	Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors	NASDAQ:VOR	Vor Biopharma Inc
2024/04/01	21 : 00	GlobeNewswire Inc.	Vor Bio to Participate in Upcoming Investor Conferences	NASDAQ:VOR	Vor Biopharma Inc
2024/03/21	05 : 05	GlobeNewswire Inc.	Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
2024/03/06	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/03/06	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/03/06	06 : 01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc
2024/03/04	22 : 00	GlobeNewswire Inc.	Vor Bio to Participate in Upcoming Investor Conferences	NASDAQ:VOR	Vor Biopharma Inc
2024/02/15	06 : 08	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:VOR	Vor Biopharma Inc
2024/02/09	07 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/02/09	07 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/02/07	22 : 00	GlobeNewswire Inc.	Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	NASDAQ:VOR	Vor Biopharma Inc
2024/02/03	06 : 01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc
2024/02/01	09 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/02/01	09 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2024/01/18	06 : 01	GlobeNewswire Inc.	Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update	NASDAQ:VOR	Vor Biopharma Inc
2024/01/06	07 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VOR	Vor Biopharma Inc
2023/12/22	06 : 01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc
2023/12/02	06 : 01	GlobeNewswire Inc.	Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:VOR	Vor Biopharma Inc
2023/11/27	22 : 00	GlobeNewswire Inc.	Vor Bio to Participate in the JMP Securities Hematology and Oncology Summit	NASDAQ:VOR	Vor Biopharma Inc
2023/11/10	06 : 01	GlobeNewswire Inc.	Vor Bio Presents Positive Data Update on Trem-cel at HSCT² Conference	NASDAQ:VOR	Vor Biopharma Inc
2023/11/09	06 : 14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2023/11/09	06 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VOR	Vor Biopharma Inc
2023/11/08	06 : 05	GlobeNewswire Inc.	Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company Update	NASDAQ:VOR	Vor Biopharma Inc
2023/11/08	06 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VOR	Vor Biopharma Inc